Novartis: A long-term partner to the healthcare ecosystem, providing the sustained investment in oncology innovation, system readiness and partnership essential to improve cancer outcomes
Dublin market lagged behind neighbouring markets
US president Donald Trump had earlier said he will impose 100 per cent import tariffs on pharma products
Automakers Volkswagen, BMW plunge with trade agreement set to lock in 15% tariffs on exports to US
European drug company bosses say the answer to a perceived lack of competitiveness in the EU is to hike medicine prices to US levels
Novartis and Sanofi CEOs push for European benchmark against US prices
Overnight comments are most detailed yet in specifying other sectors to be hit and would mark a dramatic widening of trade war
Drugmaker sees revenue growing 6% per year through to 2029
Continent’s top firms drove most of European equity gains last year
The shares dropped 4 per cent, tempering gains of 9 per cent so far this year, as analysts pointed to higher-than-expected costs and some disappointment over the 2024 goal.
Pharmaceutical-related products accounted for almost two-thirds of Irish goods exports last year
Higher interest rates and ESG requirements see Dublin 4 scheme’s capital value fall to below replacement cost level of €170 per square foot
Action against generics group Mylan continues after terms agreed with rival generics player Accord Healthcare in patent infringement case
When staff at the Irish arm of the Swiss pharma company Novartis were asked for feedback on wellness initiatives, health screening was high on the list
Expensive medicines made by Pfizer, J&J and Merck selected for talks in biggest pharma shake-up in decades
US consumer price index comes in marginally below expectations, with core prices as expected
The sector is dealing with a double whammy of an economic downturn and changes in working patterns
Agency’s figures also point to partial displacement of trade following UK’s exit from EU
Revenue fails to convince court that Swiss company should not be refunded
The medicine is used in the treatment of relapsing-remitting multiple sclerosis and contains the active ingredient fingolimod
Pharma group has moved to new global structure in 2022 in a bid to cut costs
Irish company’s software is designed to help make pathology more efficient
Drug companies scrambling to meet surging demand for patches and gels
More than 16,000 registered to take part in programme broadcast from Dublin
In lab tests the drug maintained its antiviral activity against all variants of concern
Iseq closes in positive territory despite Ryanair warning
CSO figures reveal computer services and chemicals dominate State’s exports
FTSE 100 rallies as Bank of England leaves interest rates unchanged
The Swiss pharma giant warned it expected Sandoz’s operating income to fall faster than previously expected this year
Irish scientists and companies are working on next-generation cancer therapies
Dublin-headquartered company helps patients better adhere to medication schedules
Mr Bodson, who joins from Novartis, has also served at Sainsburys Argos, EMI and Amazon
Vaccine OK raises hope of quicker recovery
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Read the digital edition of The Gloss magazine now
Weddings, Births, Deaths and other family notices
